Investor AB reports Atlas Antibodies' acquisition of evitria.

NORDIC BUSINESS REPORT-July 28, 2021-Investor AB reports Atlas Antibodies' acquisition of evitria

(C)2021 M2 COMMUNICATIONS http://www.m2.com

Swedish industrial holding company Investor AB (STO:INVEB) announced on Wednesday the acquisition of Swiss biotechnology company evitria by Atlas Antibodies, which is majority owned by Patricia Industries, part of Investor AB.

Founded in 2010, evitria is a provider of antibody expression services, specialising in CHO-based transient expression of antibodies, including bispecific and fusion antibodies, and other proteins.

Atlas Antibodies develops advanced reagents for biomedical research.

Patricia Industries will contribute its 70% of Atlas...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT